Fever-Tree (FEVR) stock rose 4% after Kepler upgraded it to Buy, raising its price target to 910p on accelerating U.S. growth and stronger earnings.
Fever-Tree (FEVR) stock climbed 4% after Kepler upgraded to Buy with 910p target. U.S. growth accelerates to 16% while earnings forecasts rise significantly.
Britain's Fever-Tree Drinks posted a 9% rise in first-half adjusted core profit, after its UK business returned to growth.
MIX with the BEST Tomorrow morning, Thursday, 10th September, Fever-Tree Drinks (LON:FEVR), the world's leading supplier of ...
Despite its latest results showing a sales downturn in the UK home market and a squeeze on margins in the US, the joint venture with Molson Coors seems set to herald the group avoiding President Trump ...
Fever-tree has claimed "strong progress" in the first half of 2026, as a hot early summer powered a return to growth in the UK and momentum built abroad ...
content.api.pressassociation.io on MSN
Fever-Tree profits knocked by £2.8m packaging tax provision
The soft drinks and mixers firm reported underlying earnings of £42.4 million for 2025, down from £50.7 million in 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results